PT  - JOURNAL ARTICLE
AU  - Esposito, Pasquale
AU  - Garbarino, Sara
AU  - Fenoglio, Daniela
AU  - Cama, Isabella
AU  - Cipriani, Leda
AU  - Campi, Cristina
AU  - Parodi, Alessia
AU  - Vigo, Tiziana
AU  - Franciotta, Diego
AU  - Altosole, Tiziana
AU  - Grosjean, Fabrizio
AU  - Viazzi, Francesca
AU  - Filaci, Gilberto
AU  - Piana, Michele
TI  - LONGITUDINAL CLUSTER ANALYSIS OF HEMODIALYSIS PATIENTS WITH COVID-19 IN THE PRE-VACCINATION ERA
AID  - 10.1101/2022.08.20.22279014
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.08.20.22279014
4099  - http://medrxiv.org/content/early/2022/08/22/2022.08.20.22279014.short
4100  - http://medrxiv.org/content/early/2022/08/22/2022.08.20.22279014.full
AB  - Coronavirus disease 2019 (COVID-19) is characterized by a high heterogeneity of clinical presentation and outcomes. This is also true for patients undergoing maintenance hemodialysis (HD), who, due to specific clinical factors and immune status, represent a distinct subgroup of COVID-19 patients.Starting from this observation in this research letter we tested and validated in two cohorts of HD patients with COVID-19 (derivation and validation cohort, respectively) an innovative model which combines linear mixed effect modeling and cluster analysis on longitudinal.This study aimed to describe a methodology allowing patient stratification from simple and widely available data.Our results could be interesting not only to improve COVID-19 management but also to support the application of longitudinal cluster analysis strategy in other clinical settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was performed according to the Declaration of Helsinki and was approved by the local Ethics Committee (N. Registro CER Liguria: 135/2020). All participants provided written informed consent before enrollment.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data underlying this article are available in Harvard Dataverse, at https://doi.org/10.7910/DVN/KDKR4V, (accessed on 16 July 2022). https://doi.org/10.7910/DVN/KDKR4V